- Home
- MYSZ vs ICU Comparison
MYSZ vs ICU Comparison
Compare MYSZ & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYSZ
- ICU
- Stock Information
- Founded
- MYSZ 1999
- ICU 2018
- Country
- MYSZ Israel
- ICU United States
- Employees
- MYSZ N/A
- ICU N/A
- Industry
- MYSZ Computer Software: Prepackaged Software
- ICU Biotechnology: Pharmaceutical Preparations
- Sector
- MYSZ Technology
- ICU Health Care
- Exchange
- MYSZ Nasdaq
- ICU Nasdaq
- Market Cap
- MYSZ 8.2M
- ICU 8.9M
- IPO Year
- MYSZ N/A
- ICU N/A
- Fundamental
- Price
- MYSZ $2.61
- ICU $1.91
- Analyst Decision
- MYSZ Strong Buy
- ICU
- Analyst Count
- MYSZ 1
- ICU 0
- Target Price
- MYSZ $3.00
- ICU N/A
- AVG Volume (30 Days)
- MYSZ 8.1M
- ICU 24.8K
- Earning Date
- MYSZ 11-14-2024
- ICU 11-13-2024
- Dividend Yield
- MYSZ N/A
- ICU N/A
- EPS Growth
- MYSZ N/A
- ICU N/A
- EPS
- MYSZ N/A
- ICU N/A
- Revenue
- MYSZ $9,632,000.00
- ICU $68,000.00
- Revenue This Year
- MYSZ $35.62
- ICU N/A
- Revenue Next Year
- MYSZ $12.88
- ICU $358.72
- P/E Ratio
- MYSZ N/A
- ICU N/A
- Revenue Growth
- MYSZ 43.89
- ICU N/A
- 52 Week Low
- MYSZ $1.05
- ICU $1.70
- 52 Week High
- MYSZ $9.40
- ICU $42.93
- Technical
- Relative Strength Index (RSI)
- MYSZ 47.69
- ICU 38.73
- Support Level
- MYSZ $2.24
- ICU $1.87
- Resistance Level
- MYSZ $3.08
- ICU $2.05
- Average True Range (ATR)
- MYSZ 0.93
- ICU 0.13
- MACD
- MYSZ -0.25
- ICU 0.02
- Stochastic Oscillator
- MYSZ 5.17
- ICU 12.90
About MYSZ My Size Inc.
My Size Inc is a USA based technology company that focuses on the development of an application that assists the consumer to accurately take the measurements of his or her own body to fit clothing without the need to try them on using a smartphone. The purpose of the company's business is to simplify the process of clothing acquisition through the Internet and to significantly reduce the rate of returns of clothing which were acquired through the internet and which are returned to the stores because of ill-fitting. The company generates its revenue through selling products to customers, and licensing cloud-enabled software subscriptions, associated software maintenance and support.
About ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.